These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26670978)

  • 1. Pioglitazone Use and Risk of Bladder Cancer--Reply.
    Ferrara A; Lewis JD; Habel LA
    JAMA; 2015 Dec; 314(23):2568-9. PubMed ID: 26670978
    [No Abstract]   [Full Text] [Related]  

  • 2. Pioglitazone Use and Risk of Bladder Cancer.
    Davies BJ
    JAMA; 2015 Dec; 314(23):2568. PubMed ID: 26670977
    [No Abstract]   [Full Text] [Related]  

  • 3. Pioglitazone Use and Risk of Bladder Cancer.
    Singh S; Suchard MA
    JAMA; 2015 Dec; 314(23):2567-8. PubMed ID: 26670976
    [No Abstract]   [Full Text] [Related]  

  • 4. No strong association is found between pioglitazone and bladder cancer.
    Wise J
    BMJ; 2015 Jul; 351():h3934. PubMed ID: 26202496
    [No Abstract]   [Full Text] [Related]  

  • 5. Pioglitazone--when is a prescription drug safe?
    Loke YK; Mattishent K
    Nat Rev Urol; 2015 Dec; 12(12):655-6. PubMed ID: 26416647
    [No Abstract]   [Full Text] [Related]  

  • 6. The Safety of Prescription Drugs.
    Sharfstein JM; Kesselheim AS
    JAMA; 2015 Jul; 314(3):233-4. PubMed ID: 26197182
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating Research on the Safety of Medical Therapies: The Responsibility of Journals to the Health of the Public.
    Fontanarosa PB; Bauchner H; Golub RM
    JAMA; 2015 Jul; 314(3):235-6. PubMed ID: 26197183
    [No Abstract]   [Full Text] [Related]  

  • 8. Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.
    Lewis JD; Habel LA; Quesenberry CP; Strom BL; Peng T; Hedderson MM; Ehrlich SF; Mamtani R; Bilker W; Vaughn DJ; Nessel L; Van Den Eeden SK; Ferrara A
    JAMA; 2015 Jul; 314(3):265-77. PubMed ID: 26197187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone and the risk of bladder cancer.
    Hillaire-Buys D; Faillie JL
    BMJ; 2012 May; 344():e3500. PubMed ID: 22653979
    [No Abstract]   [Full Text] [Related]  

  • 10. Pioglitazone and risk of bladder cancer: clarification of the design of the French study. Reply to Perez AT [letter].
    Neumann A; Weill A; Ricordeau P; Fagot JP; Alla F; Allemand H
    Diabetologia; 2013 Jan; 56(1):228-9. PubMed ID: 23143195
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.
    Fujimoto K; Hamamoto Y; Honjo S; Kawasaki Y; Mori K; Tatsuoka H; Matsuoka A; Wada Y; Ikeda H; Fujikawa J; Koshiyama H
    Diabetes Res Clin Pract; 2013 Feb; 99(2):e21-3. PubMed ID: 23228390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated Review Confirms Potential Risk of Bladder Cancer with Pioglitazone.
    Aschenbrenner DS
    Am J Nurs; 2017 Apr; 117(4):25. PubMed ID: 28333739
    [No Abstract]   [Full Text] [Related]  

  • 13. Meta-analysis confirms raised risk of bladder cancer from pioglitazone.
    Kermode-Scott B
    BMJ; 2012 Jul; 345():e4541. PubMed ID: 22763399
    [No Abstract]   [Full Text] [Related]  

  • 14. Balancing the risks and benefits for pioglitazone in type 2 diabetes.
    Johnson JA; Colmers IN
    Diabetes Res Clin Pract; 2012 Oct; 98(1):1-2. PubMed ID: 22959125
    [No Abstract]   [Full Text] [Related]  

  • 15. Eight cases of bladder cancer in pioglitazone users from India.
    Unnikrishnan R; Sundramoorthy C; Deshpande N; Sarvothaman R; Sahay RK; Mehtalia S; Venkatraman JV; Mohan V
    J Assoc Physicians India; 2012 Dec; 60():66. PubMed ID: 23781679
    [No Abstract]   [Full Text] [Related]  

  • 16. Pioglitazone and risk of bladder cancer: clarification of the design of the French study.
    Perez AT
    Diabetologia; 2013 Jan; 56(1):227. PubMed ID: 23135221
    [No Abstract]   [Full Text] [Related]  

  • 17. Pioglitazone and bladder cancer: the pros and cons.
    Panikar V
    J Assoc Physicians India; 2012 Jan; 60():72-3. PubMed ID: 22715550
    [No Abstract]   [Full Text] [Related]  

  • 18. Pioglitazone: European approval maintained despite the acknowledged risks.
    Prescrire Int; 2012 Jul; 21(129):181. PubMed ID: 22852286
    [No Abstract]   [Full Text] [Related]  

  • 19. Stay vigilant: a glitazone (pioglitazone) can hide a glitazar!
    Hillaire-Buys D; Faillie JL; Montastruc JL; Petit P
    Eur J Clin Pharmacol; 2012 Dec; 68(12):1681-3. PubMed ID: 22576730
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis.
    Zhu Z; Shen Z; Lu Y; Zhong S; Xu C
    Diabetes Res Clin Pract; 2012 Oct; 98(1):159-63. PubMed ID: 22705039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.